Clinical Q&A and Closing Comments

Clinical Q&A Panel 

Jennifer DeSimone, MD, FAAD
Inova Schar Cancer Institute

David Fisher, MD
Dana Farber Cancer Institute

Yvette Kasamon, MD
Center for Drug Evaluation and Research (CDER), FDA

Ellen Kim, MD
Perelman School of Medicine

Closing Comments
Susan Thornton, CEO
Cutaneous Lymphoma Foundation